Press Releases Ypsomed Group
Burgdorf – Intends to acquire new business in the area of injection systems.
The Ypsomed Group is well-positioned in the burgeoning Chinese diabetes market. With its newly founded subsidiary in Beijing, Ypsomed is investing in the future and, in so doing, intends to acquire new business in the area of injection systems. In addition, in early 2014, the Burgdorf, Switzerland, based diabetes specialist started commissioning the manufacturing of injection systems for the Chinese market in China itself.
